Dr. Yu Bin Lee | Tissue Engineering | Best Researcher Award
Senior Researcher at Korea Institute of Toxicology at South Korea
Dr. Yu Bin Lee is a distinguished researcher whose academic and professional journey reflects a strong commitment to advancing bioengineering and toxicology. He earned his B.S., M.S., and Ph.D. degrees in Bioengineering from Hanyang University, Seoul, under the supervision of Prof. Heungsoo Shin, where he graduated cum laude at the undergraduate level and progressed through advanced research in biomaterials and regenerative medicine. His career trajectory includes serving as a Post-doctoral Researcher at Hanyang University, followed by international research associate positions at Case Western Reserve University and the University of Illinois at Chicago under Prof. Eben Alsberg, where he specialized in tissue engineering and biomaterials. He further advanced his expertise as a Principal Scientist at Samsung Bioepis before joining the Korea Institute of Toxicology in 2021, where he currently serves as Senior Researcher. Dr. Lee’s research interests span biomaterials, tissue regeneration, 3D bioprinting, immuno-engineering, and in vitro disease modeling for drug screening and toxicological assessment. His research skills include the development of advanced hydrogels, biofabrication methods, 3D organotypic models, and cell-based therapies, which have positioned him as a leading innovator in creating functional biological systems that bridge fundamental science and clinical translation. With an h-index of 10, 816 citations by 736 documents, and 25 publications, his scientific contributions have gained significant recognition in the global research community. Dr. Lee has also received numerous awards and honors, including the Outstanding Researcher Award from the Korea Institute of Toxicology (2025), the Young Researcher Award from the Korean National Research Council of Science & Technology (2024), and multiple presentation and poster awards at international and national conferences, as well as prestigious scholarships such as the Brain Korea 21 Scholarship and National Science & Technology Scholarship. These accolades highlight both his academic excellence and leadership in advancing biomedical innovation. In conclusion, Dr. Yu Bin Lee has built a remarkable career marked by impactful research, international collaborations, and recognition for his scientific contributions. His work not only advances the frontiers of tissue engineering and toxicology but also contributes to the development of next-generation biomedical solutions, making him a pivotal figure in the field of bioengineering and applied life sciences
Profile: Scopus
Featured Publications
Kyun, M.-L., Park, D. J., Jung, H., Kim, I., Jeong, S. Y., Kim, J., Jo, M., Kwon, J.-I., Kim, J. K., Kim, D., Park, S. A., Ryu, C. S., Kim, S. K., Park, D., Lee, Y. B., & Moon, K.-S. (2025). 3D liver model for assessing immune-mediated hepatotoxicity from biopharmaceutical risks. Chemical Engineering Journal. (In press).
Jo, S., Lee, Y. B., Kim, S.-M., Lee, S. Y., Choi, M., Kyun, M.-L., Jeong, S. Y., Lee, S., Kim, J. H., Kim, Y., Kim, Y. J., Park, S., Moon, K.-S., & Kim, T.-D. (2025). Fine-tuning signal strength in CD5 CAR-NK cells for targeted T cell cancer therapy. Frontiers in Immunology. (In press).
Kyun, M.-L., Kwon, J.-I., Jung, H., Kim, J., Jo, M., Lee, Y. B., & Moon, K.-S. (2025). Developing a human immune-endothelial co-culture model for inflammatory vasculitis and drug screening. ACS Omega. (In press).
Lee, Y. B., Kyun, M.-L., Lee, Y. J., Shim, H.-E., Huh, K. M., & Kang, S.-W. (2025). Cyclodextrins as multifunctional tools for advanced biomaterials in tissue repair and regeneration. Bioactive Materials, 49, 627.
Lee, S. J., Jeon, O., Lee, Y. B., Alt, D. S., Ding, A., Tang, R., & Alsberg, E. (2025). In situ cell condensation-based cartilage tissue engineering via immediately implantable high-density stem cell core and rapidly degradable shell microgels. Advanced Composites and Hybrid Materials, 8, 1–14.
Jung, H., Kyun, M.-L., Kwon, J., Kim, J., Kim, J. K., Park, D., Lee, Y. B., & Moon, K.-S. (2024). Amplified response of drug-induced liver fibrosis via immune cell co-culture in a 3D in vitro hepatic fibrosis model. Biomaterials Science, 12, 6351.
Jeong, S. Y., Park, D., Park, T., Han, J.-S., Lee, J., Choi, C. H., Jo, M., Lee, Y. B., Kyun, M.-L., Choi, M., Park, D., & Moon, K.-S. (2024). Interspecies transcriptome profiles of human T cell activation and liver inflammation in a xenogeneic graft-versus-host disease model. Heliyon, 10, e40559.